M&A Deal Summary |
|
|---|---|
| Date | 2013-09-13 |
| Target | Rhoen-Klinikum Ag /43 Hospitals/ |
| Sector | Healthcare Services |
| Buyer(s) | Fresenius |
| Sellers(s) | Rhön-Klinikum AG |
| Deal Type | Add-on Acquisition |
| Deal Value | 3.1B EUR |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1912 |
| Sector | Medical Products |
| Employees | 190,863 |
| Revenue | 21.8B EUR (2024) |
Fresenius provides medical products, services for dialysis, hemodialysis, peritoneal dialysis. Fresenius was founded in 1912 and is based in Bad Homburg Vor Der Hoehe, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 8 |
| Sector: Healthcare Services M&A | 2 of 6 |
| Type: Add-on Acquisition M&A Deals | 2 of 5 |
| Country: Germany M&A | 1 of 2 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 2 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-07-21 |
Fenwal
Lake Zurich, Illinois, United States Fenwal, Inc. is one of the world's largest suppliers of products and services to the transfusion medicine industry. Fenwal was created with a single purpose: to provide high quality, innovative blood collection and processing products and services that support customers' missions to improve and save lives. |
Buy | $1.1B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-09 |
Novafarma Indústria Farmacêutica
Anapolis, Brazil Novafarma Indústria Farmacêutica Ltda. is a provider of comprehensive range of generic I.V. drugs, including antibiotics, analgesics and anesthetics, for the Brazilian hospital market. |
Buy | - |
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
